IPO Issue Details
Issue Price / Price Band₹85 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size33,08,800 shares (aggregating up to ₹28.12 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenNot Available
Subscription CloseNot Available
Basis of Allotment~6 days after close
Initiation of Refunds~7 days after close
Credit of Shares to Demat~7 days after close
Listing DateMon, 08 Dec 2025
UPI Mandate Deadline2025-12-03
Application & Investment Details
Retail — Min (2 Lots)₹2,72,000 — 3,200 shares
Retail — Max (13 Lots)₹1,768,000 (13 Lots)
HNI — Min (3 Lots)₹4,08,000 — 4,800 shares
QIB Quota40.28% of Issue
NII / HNI Quota16.39% of Issue
Retail Quota38.30% of Issue
Market Maker Quota5.03% of Issue
EPS (Pre-IPO)₹5.86
EPS (Post-IPO)₹6.50
P/E Ratio (Pre-IPO)14.51x
P/E Ratio (Post-IPO)13.08x
Net Offer to Public31,42,400 shares (aggregating up to ₹26.71 Cr)
Reserved for Market Maker1,66,400 shares (aggregating up to ₹1.41 Cr)
Pre-IPO Promoter Holding92,63,173 shares
Post-IPO Promoter Holding1,25,71,973 shares
About Invicta Diagnostic Ltd
Invicta Diagnostic Ltd is proposing an Initial Public Offering (IPO) on the NSE SME platform under the SME category.
The total issue size is 33,08,800 shares (aggregating up to ₹28.12 Cr).
The IPO subscription opens on the announced date and closes on the announced date. Listing is expected on 08 Dec 2025.
Investors can apply through ASBA or UPI via their broker app.
Shareholding & Lock-in
Pre-IPO Promoter Holding
92,63,173 shares
Post-IPO Promoter Holding
1,25,71,973 shares
IPO Subscription Status
Listed on 08 Dec 2025
Final subscription figures recorded below
UPI Mandate Deadline: 2025-12-03
Important Dates
Subscription OpensTo be announced
Subscription ClosesTo be announced
Basis of Allotment~6 days after close
Listing DateMon, 08 Dec 2025
UPI Mandate Deadline2025-12-03
Lot Size & Investment Table
| Application | Lots | Shares | Amount |
|---|
| Retail (Min — 2 Lots) |
2 |
3,200 |
₹272,000 |
| Retail (Max — 13 Lots) |
13 |
20,800 |
₹1,768,000 |
| S-HNI (Min — 14 Lots) |
14 |
22,400 |
₹1,904,000 |
| S-HNI (Max — 66 Lots) |
66 |
105,600 |
₹8,976,000 |
| B-HNI (Min — 67 Lots) |
67 |
107,200 |
₹9,112,000 |
* Issue Price ₹85 × Lot Size 1,600 shares
Company Financials — Restated Consolidated
(Amount in ₹ Crore)
| Particulars |
30 Sep 2025 |
31 Mar 2025 |
31 Mar 2024 |
| Revenue from Operations |
17.08 |
30.18 |
15.90 |
| EBITDA |
6.77 |
9.20 |
7.09 |
| Profit After Tax (PAT) |
4.08 |
4.93 |
3.81 |
| Net Worth |
23.68 |
13.60 |
8.67 |
| Total Assets |
34.90 |
21.22 |
15.89 |
| Reserves & Surplus |
14.42 |
5.18 |
8.54 |
| Total Borrowings |
3.72 |
3.54 |
3.81 |
| EBITDA Margin (%) |
30.57% |
— | — |
| PAT Margin (%) |
16.38% |
— | — |
Key Ratios & Valuation
Issue Price₹85
Face Value₹10.00 Per Share
Price / Book Value (P/BV)5.26
Return on Equity (RoE)44.28%
Return on Capital Employed (RoCE)42.00%
Return on Net Worth (RoNW)36.25%
PAT Margin (%)16.38%
EBITDA Margin (%)30.57%
Debt / Equity Ratio0.26
Issue Structure & Shareholding
Total Shares Offered33,08,800 (100.00%)
Net Offer to Public31,42,400 shares (aggregating up to ₹26.71 Cr)
Reserved for Market Maker1,66,400 shares (aggregating up to ₹1.41 Cr)
Pre-Issue Promoter Holding92,63,173 shares
Post-Issue Promoter Holding1,25,71,973 shares
Script CodeNot Available
Objects of the Issue
Invicta Diagnostic Ltd proposes to utilize the net proceeds raised through this IPO for the following objects as stated in the Draft Red Herring Prospectus (DRHP) filed with SEBI:
Issue Composition & Shareholding
Issue TypeBookbuilding IPO
Sale TypeFresh Capital
Total Shares Offered33,08,800 (100.00%)
Net Offer to Public31,42,400 shares (aggregating up to ₹26.71 Cr)
Reserved for Market Maker1,66,400 shares (aggregating up to ₹1.41 Cr)
Pre-Issue Promoter Holding92,63,173 shares
Post-Issue Promoter Holding1,25,71,973 shares